Transcendental Meditation for Carers of Dementia Sufferers Trial [TRANSCENDENT]

Not Applicable

Completed

• Conditions: Psychological stress; Alternative and Complementary Medicine - Other alternative and complementary medicine; Mental Health - Studies of normal psychology, cognitive function and behaviour

• Registration Number: ACTRN12613000184774
• Lead Sponsor: niversity of South Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-02-15
• Study Completion: 2014-09-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

(i) Is a non-professional, community-dwelling carer of a person with diagnosed dementia,
(ii) Has not received previous instruction on the TM technique,
(iii) Is able to provide written consent,
(iv) Is able to speak, read and understand English,
(v) Is available and willing to complete all TM / healthy lifestyle program sessions and baseline, post-intervention and follow-up assessments, and
(vi) Is able to arrange respite for the dementia sufferer when away for the TM / healthy lifestyle program sessions and assessments.

Exclusion Criteria

(i) Has a history of any condition causing moderate to severe cognitive impairment,
(ii) Has begun or ceased psychotropic medication within the past six weeks,
(iii) Has participated in a clinical trial within the past 30 days, where psychological outcomes and quality of life were outcomes of interest,
(iv) Practices some form of mind-body therapy on a regular basis,
(v) Consults a psychologist or psychiatrist at least once a week, and
(vi) Has taken a recreational drug in the past 15 days.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean health-related quality of life index score, as measured by the Assessment of Quality of Life 8-dimension (AQoL-8D) instrument[This will be assessed at baseline (week 0), post-intervention (week 12) and at follow-up (week 24).];Mean stress score, as measured by the depression, anxiety and stress scale within the WebNeuro test battery.[This will be assessed at baseline (week 0), post-intervention (week 12) and at follow-up (week 24).]